- Home
- COYA vs SEER Comparison
COYA vs SEER Comparison
Compare COYA & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- SEER
- Stock Information
- Founded
- COYA 2020
- SEER 2017
- Country
- COYA United States
- SEER United States
- Employees
- COYA N/A
- SEER N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- SEER Medicinal Chemicals and Botanical Products
- Sector
- COYA Health Care
- SEER Health Care
- Exchange
- COYA Nasdaq
- SEER Nasdaq
- Market Cap
- COYA 107.0M
- SEER 113.8M
- IPO Year
- COYA 2022
- SEER 2020
- Fundamental
- Price
- COYA $6.00
- SEER $2.27
- Analyst Decision
- COYA Strong Buy
- SEER
- Analyst Count
- COYA 5
- SEER 0
- Target Price
- COYA $16.20
- SEER N/A
- AVG Volume (30 Days)
- COYA 299.7K
- SEER 82.1K
- Earning Date
- COYA 11-06-2025
- SEER 11-06-2025
- Dividend Yield
- COYA N/A
- SEER N/A
- EPS Growth
- COYA N/A
- SEER N/A
- EPS
- COYA N/A
- SEER N/A
- Revenue
- COYA $423,452.00
- SEER $16,288,000.00
- Revenue This Year
- COYA $40.80
- SEER $25.97
- Revenue Next Year
- COYA N/A
- SEER $24.00
- P/E Ratio
- COYA N/A
- SEER N/A
- Revenue Growth
- COYA N/A
- SEER 10.52
- 52 Week Low
- COYA $4.65
- SEER $1.62
- 52 Week High
- COYA $8.29
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- COYA 45.68
- SEER 54.42
- Support Level
- COYA $6.07
- SEER $2.20
- Resistance Level
- COYA $6.50
- SEER $2.41
- Average True Range (ATR)
- COYA 0.51
- SEER 0.10
- MACD
- COYA -0.07
- SEER -0.00
- Stochastic Oscillator
- COYA 3.13
- SEER 48.15
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.